X

Vous n'êtes pas connecté

  - ZACKS.COM - All Stories - 05/Aug 22:05

Halozyme Therapeutics (HALO) Q2 Earnings and Revenues Surpass Estimates

Halozyme Therapeutics (HALO) delivered earnings and revenue surprises of +25.20% and +13.84%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Articles similaires

Sorry! Image not available at this time

Eli Lilly (LLY) Q2 Earnings and Revenues Surpass Estimates

zacks.com - 07/Aug 11:55

Lilly (LLY) delivered earnings and revenue surprises of +12.48% and +5.48%, respectively, for the quarter ended June 2025. Do the numbers hold clues...

Sorry! Image not available at this time

Crocs (CROX) Q2 Earnings and Revenues Surpass Estimates

zacks.com - 07/Aug 12:15

Crocs (CROX) delivered earnings and revenue surprises of +5.49% and +0.83%, respectively, for the quarter ended June 2025. Do the numbers hold clues...

Sorry! Image not available at this time

Crocs (CROX) Q2 Earnings and Revenues Surpass Estimates

zacks.com - 07/Aug 12:15

Crocs (CROX) delivered earnings and revenue surprises of +5.49% and +0.83%, respectively, for the quarter ended June 2025. Do the numbers hold clues...

Sorry! Image not available at this time

Backblaze, Inc. (BLZE) Q2 Earnings and Revenues Surpass Estimates

zacks.com - 07/Aug 12:25

Backblaze (BLZE) delivered earnings and revenue surprises of +120.00% and +2.42%, respectively, for the quarter ended June 2025. Do the numbers hold...

Sorry! Image not available at this time

Backblaze, Inc. (BLZE) Q2 Earnings and Revenues Surpass Estimates

zacks.com - 07/Aug 12:25

Backblaze (BLZE) delivered earnings and revenue surprises of +120.00% and +2.42%, respectively, for the quarter ended June 2025. Do the numbers hold...

Sorry! Image not available at this time

Collegium Pharmaceutical (COLL) Q2 Earnings and Revenues Surpass Estimates

zacks.com - 07/Aug 12:50

Collegium Pharmaceutical (COLL) delivered earnings and revenue surprises of +3.70% and +4.23%, respectively, for the quarter ended June 2025. Do the...

Sorry! Image not available at this time

Collegium Pharmaceutical (COLL) Q2 Earnings and Revenues Surpass Estimates

zacks.com - 07/Aug 12:50

Collegium Pharmaceutical (COLL) delivered earnings and revenue surprises of +3.70% and +4.23%, respectively, for the quarter ended June 2025. Do the...

Sorry! Image not available at this time

Celsius Holdings Inc. (CELH) Q2 Earnings and Revenues Surpass Estimates

zacks.com - 07/Aug 11:10

Celsius (CELH) delivered earnings and revenue surprises of +104.35% and +14.53%, respectively, for the quarter ended June 2025. Do the numbers hold...

Sorry! Image not available at this time

Celsius Holdings Inc. (CELH) Q2 Earnings and Revenues Surpass Estimates

zacks.com - 07/Aug 11:10

Celsius (CELH) delivered earnings and revenue surprises of +104.35% and +14.53%, respectively, for the quarter ended June 2025. Do the numbers hold...

Sorry! Image not available at this time

Ducommun (DCO) Q2 Earnings and Revenues Surpass Estimates

zacks.com - 07/Aug 11:20

Ducommun (DCO) delivered earnings and revenue surprises of +10.00% and +1.89%, respectively, for the quarter ended June 2025. Do the numbers hold...